Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Non Operating Income (2019 - 2025)

Volitionrx filings provide 7 years of Non Operating Income readings, the most recent being -$1.5 million for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 1856.14% to -$1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.8 million, a 657.22% decrease, with the full-year FY2025 number at -$1.8 million, down 657.36% from a year prior.
  • Non Operating Income hit -$1.5 million in Q4 2025 for Volitionrx, down from -$308801.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $676795.0 in Q4 2021 to a low of -$1.5 million in Q4 2025.
  • Median Non Operating Income over the past 5 years was -$1056.0 (2023), compared with a mean of $41904.0.
  • Biggest five-year swings in Non Operating Income: soared 519.5% in 2023 and later plummeted 239480.62% in 2025.
  • Volitionrx's Non Operating Income stood at $676795.0 in 2021, then dropped by 0.34% to $674476.0 in 2022, then tumbled by 108.77% to -$59126.0 in 2023, then fell by 28.35% to -$75887.0 in 2024, then plummeted by 1856.14% to -$1.5 million in 2025.
  • The last three reported values for Non Operating Income were -$1.5 million (Q4 2025), -$308801.0 (Q3 2025), and -$16263.0 (Q2 2025) per Business Quant data.